Global News
-
Global healthcare leaders advance sector decarbonisation ahead of COP28
China and India are key markets for pharmaceutical manufacturing, estimated to account for up to 50 per cent of materials…
Read More » -
International SOS unveils refreshed malaria digital learning solution for global workforces
The e-learning course is designed to equip those living in malaria-affected areas or those travelling to such regions As part…
Read More » -
AstraZeneca launches Evinova
A health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes…
Read More » -
Roche launches next-generation qPCR system to advance clinical needs in molecular diagnostics
The new system raises the bar for performance and usability while bridging the gap between translational research and in vitro…
Read More » -
Illumina launches Global Health Access Initiative
To support acceleration of pathogen sequencing in low- and middle-income countries Illumina, a global leader in DNA sequencing and array-based…
Read More » -
Lupin launches Rocuronium Bromide injection in US
The injection is indicated for inpatients and outpatients as an adjunct to general anaesthesia to facilitate both rapid sequence and…
Read More » -
Lupin, Amman Pharma in agreement for Ranibizumab Biosimilar
Pioneering access to this complex ophthalmic biosimilar medicine in the MENA Region Lupin has partnered with Amman Pharmaceuticals Industries (Amman…
Read More » -
Medtech Startup Instashield signs MoU with Montgomery County, Maryland, USA
The primary objectives of this trade mission were to foster partnerships with growth-oriented technology businesses, facilitate research and development opportunities…
Read More » -
SPARC in agreement with Johns Hopkins University and IOCB for SCD-153
SCD-153 is the first-in-class topical formulation for the treatment of Alopecia Areata Sun Pharma Advanced Research Company has entered into…
Read More » -
Intas Pharmaceuticals, Henlius Biotech in Agreement to commercialise serplulimab
Intas Pharmaceuticals has entered into an exclusive license agreement with Shanghai Henlius Biotech for the development and commercialisation of serplulimab…
Read More »
